Please wait while the formulary information is being retrieved.
Drug overview for TOBRADEX ST (tobramycin/dexamethasone):
Generic name: tobramycin/dexamethasone (TOE-bra-MYE-sin/dex-uh-METH-uh-sown)
Drug class: Ophthalmic Antibacterials
Therapeutic class: Ophthalmic Agents
Dexamethasone is a synthetic fluorinated corticosteroid. Tobramycin is an aminoglycoside antibiotic.
No enhanced Uses information available for this drug.
Generic name: tobramycin/dexamethasone (TOE-bra-MYE-sin/dex-uh-METH-uh-sown)
Drug class: Ophthalmic Antibacterials
Therapeutic class: Ophthalmic Agents
Dexamethasone is a synthetic fluorinated corticosteroid. Tobramycin is an aminoglycoside antibiotic.
No enhanced Uses information available for this drug.
DRUG IMAGES
- No Image Available
The following indications for TOBRADEX ST (tobramycin/dexamethasone) have been approved by the FDA:
Indications:
Ocular inflammation
Superficial ocular infection
Professional Synonyms:
Ophthalmic inflammation
Superficial ophthalmic infection
Indications:
Ocular inflammation
Superficial ocular infection
Professional Synonyms:
Ophthalmic inflammation
Superficial ophthalmic infection
The following dosing information is available for TOBRADEX ST (tobramycin/dexamethasone):
Dexamethasone or its sodium phosphate salt is applied topically to the eye or the ear. Potency of the sodium phosphate preparations is expressed in terms of dexamethasone phosphate. Care should be taken to avoid contamination of the tip of the ointment tube or dropper when the drug is used ophthalmically.
No enhanced Administration information available for this drug.
No dosing information available.
No generic dosing information available.
The following drug interaction information is available for TOBRADEX ST (tobramycin/dexamethasone):
There are 0 contraindications.
There are 0 severe interactions.
There are 0 moderate interactions.
The following contraindication information is available for TOBRADEX ST (tobramycin/dexamethasone):
Drug contraindication overview.
No enhanced Contraindications information available for this drug.
No enhanced Contraindications information available for this drug.
There are 4 contraindications.
Absolute contraindication.
Contraindication List |
---|
Fungal infection of eye |
Herpes simplex dendritic keratitis |
Tuberculosis of the eye |
Vaccinia virus keratitis |
There are 2 severe contraindications.
Adequate patient monitoring is recommended for safer drug use.
Severe List |
---|
Amebic infection of the eye |
Ocular hypertension |
There are 5 moderate contraindications.
Clinically significant contraindication, where the condition can be managed or treated before the drug may be given safely.
Moderate List |
---|
Diabetes mellitus |
Krukenberg spindle |
No disease contraindications |
Open angle glaucoma |
Severe myopia |
The following adverse reaction information is available for TOBRADEX ST (tobramycin/dexamethasone):
Adverse reaction overview.
No enhanced Common Adverse Effects information available for this drug.
No enhanced Common Adverse Effects information available for this drug.
There are 26 severe adverse reactions.
More Frequent | Less Frequent |
---|---|
None. |
Ocular hypertension Ocular inflammation Ocular itching Ocular redness |
Rare/Very Rare |
---|
Adrenocortical insufficiency Anaphylaxis Cataracts Central serous chorioretinopathy Corneal degeneration Corneal edema Corneal erosion Corneal ulcer Erythema multiforme Fungal infection of eye Glaucoma Globe perforation Hypercortisolism Hypersensitivity drug reaction Keratitis Optic nerve damage Punctate keratitis Reduced visual acuity Stevens-johnson syndrome Uveitis Visual changes Visual field defect |
There are 27 less severe adverse reactions.
More Frequent | Less Frequent |
---|---|
Blurred vision |
Blurred vision Conjunctival hyperemia Headache disorder Iritis Ocular irritation Ocular pain |
Rare/Very Rare |
---|
Accommodation disorder Allergic dermatitis Blepharoptosis Calcification of cornea Chemosis Conjunctival hyperemia Conjunctivitis Dizziness Dysgeusia Eye tearing Eyelid edema Foreign body sensation of eye Impaired wound healing Mydriasis Ocular infection Ocular irritation Ocular itching Ocular redness Photophobia Urticaria |
The following precautions are available for TOBRADEX ST (tobramycin/dexamethasone):
No enhanced Pediatric Use information available for this drug.
Contraindicated
Severe Precaution
Management or Monitoring Precaution
Contraindicated
None |
Severe Precaution
None |
Management or Monitoring Precaution
None |
Animal reproduction studies using systemic tobramycin dosages up to 33 times the usual human systemic dosage have not revealed evidence of impaired fertility or harm to the fetus. There are no controlled studies to date using tobramycin ophthalmic preparations in pregnant women. Tobramycin ophthalmic ointment and ophthalmic solution should be used during pregnancy only if clearly needed.
Fixed-combination ophthalmic preparations containing tobramycin and a corticosteroid (i.e., dexamethasone or loteprednol etabonate) should be used during pregnancy only if potential benefits justify potential risks to the fetus.
Fixed-combination ophthalmic preparations containing tobramycin and a corticosteroid (i.e., dexamethasone or loteprednol etabonate) should be used during pregnancy only if potential benefits justify potential risks to the fetus.
A decision should be made whether to discontinue nursing or discontinue tobramycin ophthalmic preparations, taking into account the importance of the drug to the woman. The manufacturers state that caution is advised if fixed-combination ophthalmic preparations containing tobramycin and a corticosteroid are used in nursing women.
No enhanced Geriatric Use information available for this drug.
The following prioritized warning is available for TOBRADEX ST (tobramycin/dexamethasone):
No warning message for this drug.
No warning message for this drug.
The following icd codes are available for TOBRADEX ST (tobramycin/dexamethasone)'s list of indications:
Ocular inflammation | |
H57.8 | Other specified disorders of eye and adnexa |
T86.840 | Corneal transplant rejection |
T86.8401 | Corneal transplant rejection, right eye |
T86.8402 | Corneal transplant rejection, left eye |
T86.8403 | Corneal transplant rejection, bilateral |
T86.8409 | Corneal transplant rejection, unspecified eye |
T86.841 | Corneal transplant failure |
T86.8411 | Corneal transplant failure, right eye |
T86.8412 | Corneal transplant failure, left eye |
T86.8413 | Corneal transplant failure, bilateral |
T86.8419 | Corneal transplant failure, unspecified eye |
T86.842 | Corneal transplant infection |
T86.8421 | Corneal transplant infection, right eye |
T86.8422 | Corneal transplant infection, left eye |
T86.8423 | Corneal transplant infection, bilateral |
T86.8429 | Corneal transplant infection, unspecified eye |
Superficial ocular infection | |
H10.0 | Mucopurulent conjunctivitis |
H10.01 | Acute follicular conjunctivitis |
H10.011 | Acute follicular conjunctivitis, right eye |
H10.012 | Acute follicular conjunctivitis, left eye |
H10.013 | Acute follicular conjunctivitis, bilateral |
H10.019 | Acute follicular conjunctivitis, unspecified eye |
H10.02 | Other mucopurulent conjunctivitis |
H10.021 | Other mucopurulent conjunctivitis, right eye |
H10.022 | Other mucopurulent conjunctivitis, left eye |
H10.023 | Other mucopurulent conjunctivitis, bilateral |
H10.029 | Other mucopurulent conjunctivitis, unspecified eye |
Formulary Reference Tool